IP Library Granted Patent US 11,376,390
Granted Patent B2
US 11,376,390 · App. 17/197,911 · Granted Jul 5, 2022

Systems and methods for generating nitric oxide

Inventors: Ian J. Gillerman (Somerville, MA); Gregory W. Hall (Belmont, MA); Wolfgang Scholz (Beverly, MA); David G. Zapol (San Francisco, CA)
Assignee: Third Pole, Inc.
A61M16/12A61K33/00A61M16/0057A61M16/0093A61M16/022A61M16/024A61M16/04A61M16/0666A61M16/101A61M16/107A61M16/202C01B21/32A61M2202/0275A61M2202/0283A61M2205/05A61M2205/054A61M2205/125A61M2205/3584A61M2205/502A61M2205/80A61M2205/8206A61M2209/088
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,376,390
App. No.
17/197,911
Granted
Jul 5, 2022
Kind
B2
Abstract

Systems and methods for nitric oxide generation are provided. In an embodiment, an NO generation system can include a controller and disposable cartridge that can provide nitric oxide to two different treatments simultaneously. The disposable cartridge has multiple purposes including preparing incoming gases for exposure to the NO generation process, scrubbing exhaust gases for unwanted materials, characterizing the patient inspiratory flow, and removing moisture from sample gases collected. Plasma generation can be done within the cartridge or within the controller. The system has the capability of calibrating NO and NO 2 gas analysis sensors without the use of a calibration gas.

Claims (28)

1. A nitric oxide (NO) generation system, comprising:

at least one plasma chamber configured to generate a product gas containing nitric oxide from a flow of a reactant gas; and

at least one controller configured to regulate the amount of nitric oxide in the product gas using one or more parameters as an input to the controller, the one or more parameters including information relating to at least one of the reactant gas, the product gas, and an inspiratory gas into which at least a portion of the product gas flows,

wherein the controller is configured to deliver a target number of inhaled NO molecules per unit time, the controller varying a number of molecules of NO delivered within each breath of the inspiratory gas from zero to a maximum value to deliver the target number of inhaled NO molecules per unit time.

2. The system of claim 1 , wherein a reactant gas flow rate is constant.

3. The system of claim 1 , wherein a first portion of the product gas is injected into an inspiratory gas and a second portion of the product gas is recirculated to the NO generation system to form a recirculation loop of the product gas.

4. The system of claim 1 , further comprising a scrubber for removing NO2 is positioned downstream of the at least one plasma chamber.

5. The system of claim 1 , wherein the concentration level of NO in the product gas is between 5 ppm and 5000 ppm.

6. The system of claim 1 , wherein the concentration level of NO in the product gas is between 500 ppm and 1000 ppm.

7. The system of claim 1 , wherein the predetermined maximum value of an inhaled NO concentration value is 80 ppm.

8. The system of claim 1 , wherein the NO delivered is intermittent to achieve the target number of molecules per unit time.

9. The system of claim 1 , wherein the NO delivered is continuously varied to achieve the target number of molecules per unit time.

10. The system of claim 1 , wherein the target number of NO molecules per unit time is related to the specific patient.

11. A method of generating nitric oxide (NO) comprising:

ionizing a reactant gas in a plasma chamber to generate a plasma for producing a product gas containing nitric oxide within a flow comprising the reactant gas; and

controlling the amount of nitric oxide in the product gas using one or more parameters as input to a control algorithm used by one or more controllers to control the plasma chamber, at least one of the one or more parameters being related to information relating to at least one of the reactant gas, the product gas, and an inspiratory gas into which at least a portion of the product gas flows,

wherein the controller is configured to deliver a target number of inhaled NO molecules per unit time, the controller varying a number of molecules of NO delivered within each breath of the inspiratory gas from zero to a maximum value to deliver the target number of inhaled NO molecules per unit time.

12. The method of claim 11 , wherein a reactant gas flow rate is constant.

13. The method of claim 11 , wherein the predetermined maximum value of an inhaled NO concentration value is 80 ppm.

14. The method of claim 11 , wherein the NO delivered is intermittent to achieve the target number of molecules per unit time.

15. The method of claim 11 , wherein the NO delivered is continuously varied to achieve the target number of molecules per unit time.

16. The method of claim 11 , wherein the target number of NO molecules per unit time is related to the specific patient.

17. The method of claim 11 , wherein a concentration of NO in the product gas is between 5 ppm and 5000 ppm.

18. The method of claim 11 , wherein a concentration of NO in the product gas is between 500 ppm and 1000 ppm.

19. A method of delivering nitric oxide (NO) comprising:

providing a gas flow of nitric oxide; and

controlling an amount of nitric oxide introduced into an inspiratory flow using one or more parameters as input to a control algorithm used by one or more controllers, at least one of the one or more parameters being related to information relating to at least one of the reactant gas, the product gas, and an inspiratory gas into which at least a portion of the product gas flows,

wherein the controller is configured to deliver a target number of inhaled NO molecules per unit time, the controller varying a number of molecules of NO delivered within each breath of the inspiratory gas from zero to a maximum value to deliver the target number of inhaled NO molecules over the unit time.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Mar 19, 2024
From: AVENUE VENTURE OPPORTUNITIES FUND L.P.
To: THIRD POLE, INC.
Reel/Frame 066825/0518 →
SECURITY INTEREST Recorded Mar 18, 2024
From: THIRD POLE, INC.
To: AMERICAN MONEY MANAGEMENT CORPORATION
Reel/Frame 066812/0657 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 10, 2021
From: ZAPOL, DAVID G.; HALL, GREGORY W.; SCHOLZ, WOLFGANG; GILLERMAN, IAN J.
To: THIRD POLE, INC.
Reel/Frame 056500/0978 →
SECURITY AGREEMENT Recorded Apr 12, 2021
From: THIRD POLE, INC.
To: AVENUE VENTURE OPPORTUNITIES FUND, L.P.
Reel/Frame 055986/0148 →
Continuity (11)
Continuation 16909722 · Jun 23, 2020
Continuation 16697498 · Nov 27, 2019
Continuation 16388464 · Apr 18, 2019
Continuation 15907241 · Feb 27, 2018
Provisional Application 62614492 · Jan 7, 2018
Provisional Application 62574173 · Oct 18, 2017
Provisional Application 62553572 · Sep 1, 2017
Provisional Application 62509394 · May 22, 2017
Provisional Application 62463943 · Feb 27, 2017
Provisional Application 62463956 · Feb 27, 2017
Related Publication 20210268221A1 · Sep 2, 2021
Cited By (5)
US 12,509,349 US 12,522,501 US 12,569,628 US 12,576,234 US 12,606,436